Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
New research suggests that patients with adrenal tumors that secrete a hormone called cortisol are at higher risk of suffering cardiovascular events and increased mortality. Investigators say their findings may lead to better clinical management of patients with these tumors.
This is according to a new study published in The Lancet Diabetes & Endocrinology.
Adrenal tumors (adrenal incidentalomas) can often produce a sex hormone called cortisol. High secretion of cortisol can lead to Cushing's syndrome (overt hypercortisolism).
Symptoms include weight gain, thinning skin that is easily bruised, appearance of stretch marks and decreased interest in sex.
Because these symptoms are fairly general, they can be hard to spot. Therefore, adrenal tumors are often referred to as "silent" tumors.
Many of these tumors are found by accident as patients undergo computed tomography (CT) scans. According to the research team, led by Prof. Renato Pasquali of the S Orsola-Malpighi Hospital in Bologna, Italy, approximately 4% of CT scans coincidentally uncover an adrenal tumor.
But the investigators say there is limited evidence detailing how these tumors progress, meaning clinicians are unclear how to manage them once they are discovered.
With the aim of uncovering how adrenal tumors advance, the research team analyzed 198 patients with adrenal incidentalomas who were referred to the endocrinology unit of the S Orsola-Malpighi Hospital between 1995 and 2010.
All patients were assessed every 18-30 months for the first 5 years, and the mean follow-up period was 7.5 years.
At each assessment, the researchers determined whether the patients' adrenal tumors were secreting cortisol and at what measures, using a dexamethasone suppression test (DST).
At the end of the follow-up period, researchers found that 114 patients had stable non-secreting adrenal tumors, 61 patients had either subclinical Cushing's syndrome or a stable intermediate phenotype tumor, while 23 had adrenal tumors that had worsened in its secretion levels.
The investigators found that, compared with patients who had non-secreting adrenal tumors, individuals with either subclinical Cushing's syndrome or a stable intermediate phenotype tumor, or those whose tumors had worsened in secreting patterns, were at a significantly higher risk of experiencing cardiovascular events.
Furthermore, the research team found that these individuals also had lower survival rates for all-cause mortality.
Commenting on the results of the study, the researchers say:
"Our findings are important because they add to the previously scant information about adrenal incidentalomas, which will be of use to doctors who are seeing an increasing number of patients with these masses.
We have shown that subclinical hypercortisolism (Cushing's syndrome) can be deleterious in individuals with adrenal masses, and this condition can develop even in people with non-secreting adrenal adenomas at baseline."
Based on their findings, the researchers suggest that patients with adrenal tumors should undergo periodic DST tests to determine whether they are heading toward cortisol overproduction.
They note that for patients with mild hypercortisolism, surgery may be the best option, particularly if they are at higher risk of experiencing cardiovascular events.
"However," they conclude, "medical treatment for bilateral forms of hypercortisolism should be investigated by specific follow-up studies designed for this reason."
In a comment piece linked to the study, Prof. Rosario Pivonello, of the Università Federico II in Naples, Italy, says the study findings support the importance of long-term clinical hormonal monitoring for patients with adrenal tumors.
"Furthermore," Prof. Pivonello adds, "clinical monitoring of cardiometabolic risks seems to be important in these patients, particularly in those with subclinical Cushing's syndrome and intermediate phenotype adrenal incidentalomas, for whom medical or surgical intervention could be needed."
Written by Honor Whiteman
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing’s syndrome: a 15-year retrospective study, Guido Di Dalmazi, Valentina Vicennati, Silvia Garelli, Elena Casadio, Eleonora Rinaldi, Emanuela Giampalma, Cristina Mosconi, Rita Golfieri, Alexandro Paccapelo, Uberto Pagotto, Renato Pasquali, published in The Lancet Diabetes & Endocrinology, 29 January 2014. Abstract
Visit our Cardiovascular / Cardiology category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Whiteman, Honor. "Adrenal tumors: hormone secretion linked to cardiovascular events." Medical News Today. MediLexicon, Intl., 29 Jan. 2014. Web.
23 Apr. 2014. <http://www.medicalnewstoday.com/articles/271822>
Whiteman, H. (2014, January 29). "Adrenal tumors: hormone secretion linked to cardiovascular events." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/271822.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.